Vir Biotechnology, Inc. (VIR)
9.67
+0.41
(+4.43%)
USD |
NASDAQ |
Mar 16, 16:00
9.70
+0.03
(+0.31%)
After-Hours: 16:48
Vir Biotechnology EPS Diluted (Quarterly) : -0.3083 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 0.0893 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Xeris Biopharma Holdings, Inc. | 0.0615 |
| Gossamer Bio, Inc. | -0.2115 |
| Sensei Biotherapeutics, Inc. | -3.915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.92M |
| Revenue (Quarterly) | 64.07M |
| Total Expenses (Quarterly) | 106.99M |
| Enterprise Value | 1.109B |
| Gross Profit Margin (Quarterly) | 95.44% |
| Profit Margin (Quarterly) | -66.99% |
| Earnings Yield | -32.72% |
| Normalized Earnings Yield | -32.22 |